688373 盟科藥業
按盤價 
5.390 +0.120 (+2.277%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -41.565 | -41.120 | -26.660 | -42.749 | -30.320 |
| 總資產報酬率 ROA (%) | -27.233 | -31.593 | -20.532 | -34.349 | -23.403 |
| 投入資產回報率 ROIC (%) | -30.234 | -33.692 | -21.557 | -37.106 | -26.955 | 邊際利潤分析 |
| 銷售毛利率 (%) | 82.229 | 81.608 | 81.699 | 92.449 | -- |
| 營業利潤率 (%) | -292.245 | -452.655 | -462.460 | -3,343.976 | -- |
| 息稅前利潤/營業總收入 (%) | -284.470 | -448.462 | -435.981 | -2,911.436 | -- |
| 淨利潤/營業總收入 (%) | -298.574 | -463.914 | -456.987 | -2,953.915 | -- | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 104.222 | 107.841 | 121.401 | 120.365 | 112.284 |
| 價值變動淨收益/利潤總額(%) | -4.150 | -8.032 | -8.394 | -4.654 | 0.163 |
| 營業外收支淨額/利潤總額(%) | 0.005 | 1.024 | -1.200 | -13.224 | -12.172 | 償債能力分析 |
| 流動比率 (X) | 6.789 | 7.715 | 11.906 | 5.410 | 19.930 |
| 速動比率 (X) | 6.434 | 7.441 | 11.716 | 5.293 | 19.761 |
| 資產負債率 (%) | 41.524 | 28.630 | 18.906 | 32.406 | 7.283 |
| 帶息債務/全部投入資本 (%) | 26.086 | 13.112 | 9.154 | 7.511 | -2.499 |
| 股東權益/帶息債務 (%) | 249.656 | 602.728 | 918.363 | 973.704 | -4,001.456 |
| 股東權益/負債合計 (%) | 140.823 | 249.282 | 428.927 | 208.583 | 1,273.134 |
| 利息保障倍數 (X) | -36.519 | -50.535 | -20.766 | -69.367 | -58.129 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 72.751 | 65.595 | 46.745 | 66.585 | -- |
| 存貨周轉天數 (天) | 646.068 | 640.488 | 671.209 | 5,171.330 | -- |
| 備註： | 即時報價更新時間為 08/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
